TLDR Salesforce agreed to acquire m3ter, a consumption-based billing platform, to expand its Agentforce Revenue Management suite Financial terms were not disclosedTLDR Salesforce agreed to acquire m3ter, a consumption-based billing platform, to expand its Agentforce Revenue Management suite Financial terms were not disclosed

Salesforce (CRM) Stock: Institutional Buying, Earnings Beat — Now an Acquisition Too

2026/06/09 22:29
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Salesforce agreed to acquire m3ter, a consumption-based billing platform, to expand its Agentforce Revenue Management suite
  • Financial terms were not disclosed; the deal is expected to close in Q2 of Salesforce’s fiscal year 2027
  • CRM opened at $182.72, trading down 1.6%, well below its 52-week high of $276.80
  • Salesforce beat Q1 earnings estimates with EPS of $3.88 vs. $3.13 expected, on revenue of $11.13 billion
  • Institutional investors hold 80.43% of CRM stock, with a consensus analyst rating of “Moderate Buy” and average price target of $260.85

Salesforce (CRM) announced Monday it has signed an agreement to acquire m3ter, a metering and rating platform built for consumption-based billing. The deal will add high-volume mediation, metering, and rating capabilities to Agentforce Revenue Management.

CRM opened at $182.72 on Tuesday, down 1.6% on the day, sitting closer to its 52-week low of $163.52 than its high of $276.80.


CRM Stock Card
Salesforce, Inc., CRM

m3ter’s platform works in near real-time at enterprise scale. It lets customers ingest product usage data, configure billing scenarios, and automate monetization data flows across CRM, ERP, and quote-to-cash systems.

Financial terms were not disclosed. The deal is expected to close in Q2 of Salesforce’s fiscal year 2027, subject to customary closing conditions.

Strong Earnings Back the Move

The acquisition comes shortly after a solid earnings print. Salesforce reported EPS of $3.88 for Q1, beating the $3.13 consensus estimate by $0.75. Revenue came in at $11.13 billion, up 13.3% year-over-year, slightly ahead of the $11.05 billion estimate.

The company’s FY2027 guidance sits at $14.06–$14.12 EPS, with Q2 2027 guidance of $3.25–$3.27 EPS.

Salesforce also has a $25 billion share buyback plan in place, authorized in March, covering up to 14.1% of outstanding stock. A quarterly dividend of $0.44 per share is set for July 2, with a record date of June 11.

Two directors, Laura Alber and David Blair Kirk, each purchased roughly $500,000 worth of stock in March at prices around $194.58–$194.62 per share.

Institutional Interest Remains Strong

Institutional ownership stands at 80.43% of CRM stock. Norges Bank opened a new position worth approximately $3.18 billion in Q4. Capital World Investors increased its stake by 159% in Q3, now holding 17.3 million shares worth $4.1 billion. Capital International Investors raised its position by 13.3% in Q4 to 22.7 million shares.

Marks Group Wealth Management added 11,897 shares in Q4, a 31.9% increase, bringing its total holding to 49,177 shares valued at roughly $13 million.

Analyst price targets vary widely. JPMorgan holds an “overweight” rating with a $320 target. BMO Capital Markets rates it “outperform” with a $215 target. Royal Bank of Canada cut its target to $210 with a “sector perform.” The consensus sits at “Moderate Buy” with an average target of $260.85.

The stock’s 50-day moving average is $181.25, and its 200-day moving average is $208.35, with a market cap of $149.64 billion and a P/E ratio of 21.15.

The post Salesforce (CRM) Stock: Institutional Buying, Earnings Beat — Now an Acquisition Too appeared first on CoinCentral.

Market Opportunity
Audiera Logo
Audiera Price(BEAT)
$4.67826
$4.67826$4.67826
+1.10%
USD
Audiera (BEAT) Live Price Chart

Predict & Trade to Win Rewards

Predict & Trade to Win RewardsPredict & Trade to Win Rewards

Guaranteed rewards with $500,000 prize pool

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage